Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What's the cost of fintepla for pharmacies?

See the DrugPatentWatch profile for fintepla

Fintepla (finerenone) is a prescription medication used to treat chronic kidney disease (CKD) in adults with type 2 diabetes. Because it’s a newer drug, its list price (also called the “average wholesale price” or “MSRP”) can vary depending on a number of factors:

Factor How it influences cost
Country/Region Pricing is set by national health authorities, insurers, or pharmacy benefit managers. In the United States, the price is higher than in many European or Asian markets.
Insurance coverage Most U.S. insurers cover Fintepla after a prior‑authorization or step‑therapy review. The patient’s copay or coinsurance amount can range from a few dollars to over $200 a month, depending on the formulary tier.
Pharmacy discount programs Some pharmacies participate in manufacturer discount programs (e.g., the “Fintepla Savings Card”) that can reduce the patient’s out‑of‑pocket cost by 20‑30 % or more.
Specialty pharmacy vs. retail pharmacy Specialty pharmacies often provide more extensive support services (e.g., adherence counseling), and they may negotiate a slightly lower wholesale price or offer patient assistance programs.

Rough U.S. pricing snapshot (2024)

  • List price: ≈ $1,200–$1,400 per month (≈ $40–$50 per daily dose).
  • Typical patient copay (depending on insurance tier): $10–$200/month.
  • Manufacturer’s savings card: Up to 30 % off the patient’s copay for uninsured or under‑insured patients.

NOTE: These figures are estimates; the actual cost can differ substantially for a particular pharmacy or insurer.

How pharmacies determine the “cost” they pay

  1. Wholesale acquisition cost (WAC) – the price the pharmacy pays the manufacturer or distributor before any discounts.
  2. Manufacturer rebates/discounts – many pharma companies offer rebates to pharmacy benefit managers (PBMs) or insurers; this reduces the effective cost for the pharmacy.
  3. PBM negotiated price – PBMs negotiate with manufacturers and pharmacies to set the “final retail price” that the pharmacy receives after rebates.

Pharmacies generally mark up the drug to cover dispensing costs and overhead, but the net revenue they receive after all rebates is often lower than the WAC.

Getting the most accurate cost for your pharmacy

  • Check the drug’s “price lookup” portal (e.g., Red Book, Micromedex) for the latest wholesale cost.
  • Ask the manufacturer: Fintepla’s manufacturer (Bristol‑Myers Squibb) maintains a pharmacy‑centered pricing portal that provides current pricing and reimbursement information.
  • Consult your PBM: They can give you the negotiated rate that your pharmacy will receive.

Bottom line

The cost of Fintepla for a pharmacy depends on negotiated rebates, the country, and whether the pharmacy is a specialty or retail site. The list price in the U.S. is roughly $1,200–$1,400/month, but the pharmacy’s net cost after discounts is usually lower. For the most accurate figure, contact the manufacturer’s pharmacy liaison or your pharmacy benefit manager.



Other Questions About Fintepla :

How much does fintepla cost per unit for wholesalers? Does fintepla offer patient assistance programs? What s the list price of fintepla for wholesalers? Are there any discounts or rebates for fintepla? How can i get financial help for fintepla? What is the wholesale priof fintepla in the usa? What is the price of fintepla for retailers?